Integra LifeSciences
IART
249 hedge funds and large institutions have $4.87B invested in Integra LifeSciences in 2018 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 96 increasing their positions, 84 reducing their positions, and 40 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 84
14% more call options, than puts
Call options by funds: $7.57M | Put options by funds: $6.64M
4.26% more ownership
Funds ownership: 82.58% → 86.85% (+4.3%)
4% more capital invested
Capital invested by funds: $4.67B → $4.87B (+$195M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less funds holding
Funds holding: 257 → 249 (-8)
10% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 40
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$46.5M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$33.5M |
| 3 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$26.3M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$20.6M |
| 5 |
Millennium Management
New York
|
-$19.4M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
II
276
Ibex Investors
Denver,
Colorado
| – | -$389K | -6,034 | Closed |
|
|
BLA
277
Balter Liquid Alternatives
Boston,
Massachusetts
| – | -$358K | -5,715 | Closed |
|
|
CIM
278
CIM Investment Management
Pittsburgh,
Pennsylvania
| – | -$262K | -4,062 | Closed |
|
279
Balyasny Asset Management
Chicago,
Illinois
| – | -$225K | -3,489 | Closed |
|
|
EBIM
280
Eagle Boston Investment Management
Boston,
Massachusetts
| – | -$223K | -3,477 | Closed |
|
|
ZCA
281
Zeke Capital Advisors
Berwyn,
Pennsylvania
| – | -$204K | -3,163 | Closed |
|
|
RWP
282
RWA Wealth Partners
Newton,
Massachusetts
| – | -$36K | -555 | Closed |
|
|
FHA
283
Flagship Harbor Advisors
Boston,
Massachusetts
| – | -$3K | -50 | Closed |
|
|
FIA
284
FNY Investment Advisers
New York
| – | -$3K | -47 | Closed |
|
|
ASN
285
Advisory Services Network
Atlanta,
Georgia
| – | -$1K | -20 | Closed |
|
|
GFP
286
Gryphon Financial Partners
Columbus,
Ohio
| – | -$1K | -19 | Closed |
|
|
MCM
287
Monument Capital Management
Alexandria,
Virginia
| – | +$373 | +6 | New |
|
|
CAG
288
Csenge Advisory Group
Clearwater,
Florida
| – | +$994 | +16 | New |
|
IART Hedge Fund Activity: Q3 2018 in Review
249 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2018, worth a combined $4.87B — up 4.2% from $4.67B a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of IART and 36 opened new positions — a net loss of 4 holders — while 84 trimmed existing stakes and 96 added.
The largest buyer was Wellington Management Group, adding an estimated $87.4M. The largest seller was Goldman Sachs, cutting an estimated $46.5M.
- 249 institutional investors held Integra LifeSciences (IART) as of Q3 2018, down from 257 in Q2 2018.
- Funds reported $4.87B of Integra LifeSciences stock for Q3 2018, up 4.2% quarter-over-quarter.
- 36 funds opened new Integra LifeSciences positions in Q3 2018 and 40 closed out, a net change of -4 holders.
- The largest Integra LifeSciences buyer in Q3 2018 was Wellington Management Group, an estimated $87.4M added.
- The largest Integra LifeSciences seller in Q3 2018 was Goldman Sachs, an estimated $46.5M sold.
Based on aggregated 13F filings for Q3 2018.